38 Studios Snaps Up Big Huge Games, EMC Buy Configuresoft, Proteon Therapeutics Picks up $12M, & More Boston-Area Deals News

5/29/09

Evidently the word of the week for many New England’s tech firms was acquisition.

Digital Lumens of Salem, MA, raised $6.3 million in a round of equity financing. The startup, whose investors were not named in the filing, aims to make lighting products that use only 10 percent as much energy as other products.

—Natick, MA-based OutSmart Power Systems closed a $2 million seed round of financing from Bainco International Investors, Clean Energy Venture Group, and Manifold Products, among others. OutSmart, which was spun off from Manifold in 2008, is developing systems to manage energy usage and other activities in commercial buildings.

—Mobile marketing software developer Celtra of Cambridge, MA, raised $1.2 million in a Series A round of financing from Slovenian venture firm RSG Capital. Celtra plans to establish its European hub in Ljubljana, Slovenia.

38 Studios of Maynard, MA, nearly doubled its size by acquiring Maryland-based Big Huge Games. Wade took a look at the history behind the deal and what it means for the future of the Massachusetts video game company, which was founded by Boston Red Sox star Curt Schilling.

—Waltham, MA-based Crosscheck Networks, a maker of tools for testing Web-based applications before they’re deployed, acquired Waltham-based Forum Systems, a maker of security and authentication tools for Web-based software.

—Scenic Technology, a Needham, MA-based maker of Microsoft .NET-based software for tracking barcodes and RFID tags, raised $1.4 million of a planned $2.1 equity round.

—EMC (NYSE:EMC) announced plans to acquire Colorado Springs, CO-based Configuresoft. The deal will help Hopkinton, MA-based EMC increase its presence in the market for software to manage physical and virtual servers, Wade explains.

—Proteon Therapeutics, a developer of drugs for kidney and vascular diseases based in Waltham, MA, raised $12 million in a second close if its Series B financing, bringing the total for the round to $50 million. The new financing came mainly from Bessemer Venture Partners and Devon Park Bioventures.

By posting a comment, you agree to our terms and conditions.